Drug recall · June 27, 2012
Zemplar recall
Why: CGMP Deviations: There is potential that Abbott's third party manufacturer, Hospira, may have applied a foreign (incorrect) stopper to vials in a specific lot of Zemplar Injection.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Zemplar (paricalcitol) Injection, 5 mcg/mL in 2 mL multi-dose vials, 25 vial carton, Rx only, Manufactured by Hospira, Inc. For Abbott Laboratories, North Chicago, IL 60064, USA, NDC 0074-1658-05
- Lots / codes
Lot #: 11-122-DK, Exp 10/13
- Quantity
- 121,000 vials
- Company
- Abbott Laboratories, Abbott Park, IL
- Distribution
- Nationwide
- Initiated
- May 14, 2012 · Voluntary: Firm initiated
- Classified
- June 18, 2012
- Reported
- June 27, 2012
- Ended
- December 3, 2012
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Paricalcitol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.